tiprankstipranks
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
US Market
CAI
Caris Life Sciences, Inc.
RESEARCH TOOLSreports
Want to see CAI full AI Analyst Report?

Caris Life Sciences, Inc. (CAI) Income Statement

136 Followers

Caris Life Sciences, Inc. Income Statement

Last quarter (Q4 2025), Caris Life Sciences, Inc.'s total revenue was $292.89M, an increase of 190.48% from the same quarter last year. In Q4, Caris Life Sciences, Inc.'s net income was $81.96M. See Caris Life Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 20
Total Revenue
$ 812.03M$ 412.26M$ 306.13M$ 258.49M$ 294.01M
Gross Profit
$ 539.17M$ 178.78M$ 89.31M$ 80.02M$ 184.16M
Operating Expenses
$ 494.06M$ 435.90M$ 408.86M$ 395.78M$ 45.07M
Depreciation and Amortization
$ 22.61M$ 48.91M$ 49.00M$ 48.25M$ 110.65M
EBITDA
$ 11.38M$ -182.95M$ -260.80M$ -245.89M$ 254.46M
Operating Income
$ 45.11M$ -257.12M$ -319.55M$ -315.76M$ 139.09M
Other Income/Expenses
$ -113.20M$ -24.77M$ -21.86M$ -5.07M$ -109.55M
Pretax Income
$ -68.09M$ -281.89M$ -341.42M$ -320.83M$ 29.53M
Net Income
$ -537.96M$ -281.89M$ -341.42M$ -320.83M$ 27.73M
Per Share Metrics
Basic EPS
$ -1.90$ -2.70$ -1.82$ -1.57$ 1.55
Diluted EPS
$ -1.90$ -2.70$ -1.82$ -1.57$ 1.55
Weighted Average Shares Outstanding
 1.67B 254.66M 254.66M 254.79M 17.95M
Weighted Average Shares Outstanding (Diluted)
 1.67B 254.66M 254.66M 254.79M 17.95M
Currency in USD

Caris Life Sciences, Inc. Earnings and Revenue History